218 related articles for article (PubMed ID: 8729099)
1. Antioxidants, lipoprotein oxidation, and arterial function.
Bruckdorfer KR
Lipids; 1996 Mar; 31 Suppl():S83-5. PubMed ID: 8729099
[TBL] [Abstract][Full Text] [Related]
2. Macrophage foam cell formation during early atherogenesis is determined by the balance between pro-oxidants and anti-oxidants in arterial cells and blood lipoproteins.
Aviram M
Antioxid Redox Signal; 1999; 1(4):585-94. PubMed ID: 11233155
[TBL] [Abstract][Full Text] [Related]
3. Vascular thrombogenicity induced by progressive LDL oxidation: protection by antioxidants.
Banfi C; Camera M; Giandomenico G; Toschi V; Arpaia M; Mussoni L; Tremoli E; Colli S
Thromb Haemost; 2003 Mar; 89(3):544-53. PubMed ID: 12624640
[TBL] [Abstract][Full Text] [Related]
4. The influence of oxidized lipoproteins, oxidation products and antioxidants on the release of nitric oxide from the endothelium and the response of platelets to nitric oxide.
Bruckdorfer KR; Naseem KM; Mohammadi B; Chirico S; Ettelaie C; Gleeson A; Young T; Adam JM; Wilbourn B; Skinner VO; Goodall AH; Khan J; Gates SC; Jacobs M
Biofactors; 1997; 6(2):191-9. PubMed ID: 9260001
[No Abstract] [Full Text] [Related]
5. Glyc-oxidized LDL impair endothelial function more potently than oxidized LDL: role of enhanced oxidative stress.
Galle J; Schneider R; Winner B; Lehmann-Bodem C; Schinzel R; Münch G; Conzelmann E; Wanner C
Atherosclerosis; 1998 May; 138(1):65-77. PubMed ID: 9678772
[TBL] [Abstract][Full Text] [Related]
6. Oxidized lipoproteins and nitric oxide.
Jessup W
Curr Opin Lipidol; 1996 Oct; 7(5):274-80. PubMed ID: 8937516
[TBL] [Abstract][Full Text] [Related]
7. Dietary probucol preserves endothelial function in cholesterol-fed rabbits by limiting vascular oxidative stress and superoxide generation.
Keaney JF; Xu A; Cunningham D; Jackson T; Frei B; Vita JA
J Clin Invest; 1995 Jun; 95(6):2520-9. PubMed ID: 7769097
[TBL] [Abstract][Full Text] [Related]
8. Oxidized low-density lipoprotein inhibits endothelium-dependent vasodilation by an antioxidant-sensitive, lysophosphatidylcholine-independent mechanism.
Chan H; Lougheed M; Laher I; Steinbrecher UP
J Cardiovasc Pharmacol; 2003 Jun; 41(6):856-65. PubMed ID: 12775962
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of low-density lipoprotein oxidation by oral herbal mixtures Maharishi Amrit Kalash-4 and Maharishi Amrit Kalash-5 in hyperlipidemic patients.
Sundaram V; Hanna AN; Lubow GP; Koneru L; Falko JM; Sharma HM
Am J Med Sci; 1997 Nov; 314(5):303-10. PubMed ID: 9365332
[TBL] [Abstract][Full Text] [Related]
10. Ascorbic acid enhances 17 beta-estradiol-mediated inhibition of oxidized low density lipoprotein formation.
Hwang J; Peterson H; Hodis HN; Choi B; Sevanian A
Atherosclerosis; 2000 Jun; 150(2):275-84. PubMed ID: 10856519
[TBL] [Abstract][Full Text] [Related]
11. Oxidized low density lipoproteins inhibit relaxations of porcine coronary arteries. Role of scavenger receptor and endothelium-derived nitric oxide.
Tanner FC; Noll G; Boulanger CM; Lüscher TF
Circulation; 1991 Jun; 83(6):2012-20. PubMed ID: 2040054
[TBL] [Abstract][Full Text] [Related]
12. How does ascorbic acid prevent endothelial dysfunction?
May JM
Free Radic Biol Med; 2000 May; 28(9):1421-9. PubMed ID: 10924860
[TBL] [Abstract][Full Text] [Related]
13. Probucol and other antioxidants prevent the inhibition of endothelium-dependent relaxation by low density lipoproteins.
Plane F; Jacobs M; McManus D; Bruckdorfer KR
Atherosclerosis; 1993 Oct; 103(1):73-9. PubMed ID: 8280187
[TBL] [Abstract][Full Text] [Related]
14. Antioxidants and atherosclerotic heart disease.
Diaz MN; Frei B; Vita JA; Keaney JF
N Engl J Med; 1997 Aug; 337(6):408-16. PubMed ID: 9241131
[TBL] [Abstract][Full Text] [Related]
15. Macrophages, endothelial cells, and lipoprotein oxidation in the pathogenesis of atherosclerosis.
Rosenfeld ME; Palinski W; Ylä-Herttuala S; Carew TE
Toxicol Pathol; 1990; 18(4 Pt 1):560-71. PubMed ID: 2091235
[TBL] [Abstract][Full Text] [Related]
16. Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions.
Siess W; Zangl KJ; Essler M; Bauer M; Brandl R; Corrinth C; Bittman R; Tigyi G; Aepfelbacher M
Proc Natl Acad Sci U S A; 1999 Jun; 96(12):6931-6. PubMed ID: 10359816
[TBL] [Abstract][Full Text] [Related]
17. Low density lipoprotein is protected from oxidation and the progression of atherosclerosis is slowed in cholesterol-fed rabbits by the antioxidant N,N'-diphenyl-phenylenediamine.
Sparrow CP; Doebber TW; Olszewski J; Wu MS; Ventre J; Stevens KA; Chao YS
J Clin Invest; 1992 Jun; 89(6):1885-91. PubMed ID: 1601995
[TBL] [Abstract][Full Text] [Related]
18. Macrophage-derived foam cells freshly isolated from rabbit atherosclerotic lesions degrade modified lipoproteins, promote oxidation of low-density lipoproteins, and contain oxidation-specific lipid-protein adducts.
Rosenfeld ME; Khoo JC; Miller E; Parthasarathy S; Palinski W; Witztum JL
J Clin Invest; 1991 Jan; 87(1):90-9. PubMed ID: 1985115
[TBL] [Abstract][Full Text] [Related]
19. Oxidized lipoproteins and endothelium.
Pirillo A; Zhu W; Norata GD; Zanelli T; Barberi L; Roma P; Catapano AL
Clin Chem Lab Med; 2000 Feb; 38(2):155-60. PubMed ID: 10834403
[TBL] [Abstract][Full Text] [Related]
20. Endothelium-derived relaxing factor (nitric oxide), lipoprotein oxidation and atherosclerosis.
Bruckdorfer KR; Jacobs M; Rice-Evans C
Biochem Soc Trans; 1990 Dec; 18(6):1061-3. PubMed ID: 2088806
[No Abstract] [Full Text] [Related]
[Next] [New Search]
